• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, January 11, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Antiepileptics increase the risk of pneumonia among persons with Alzheimer’s disease

Bioengineer by Bioengineer
March 21, 2019
in Chemistry
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

People with Alzheimer’s disease using antiepileptic drugs have twice the risk of pneumonia compared to non-users, a new study from the University of Eastern Finland shows. The risk was highest in the beginning of use, but remained on an elevated level even in long-term use. The results were published in the Journal of Alzheimer’s Disease.

Of the specific drugs, phenytoin, carbamazepine, valproic acid and pregabalin were associated with an increased risk of pneumonia. Relatively few – less than 10 per cent – of the antiepileptic users had been diagnosed with epilepsy and thus, it is likely that many used these drugs for other indications, such as neuropathic pain and behavioral symptoms of dementia. Some antiepileptic drugs have sedative effects which may explain the associated risk of pneumonia.

This was the first study investigating antiepileptic use and the risk of pneumonia among persons with Alzheimer’s disease. A previous study assessed the risk among younger adults and did not find a risk increase.

“Further research into whether older persons are more sensitive to the effects of antiepileptic drugs is needed. Persons with Alzheimer’s disease have a higher risk of pneumonia and pneumonia-related mortality than persons without the disease. For this reason, it is important to carefully assess the risks and benefits of drug use, especially for other indications than epilepsy,” Senior Researcher Heidi Taipale from the University of Eastern Finland says.

The study was based on the nationwide register-based MEDALZ study conducted at the University of Eastern Finland. For this study, 5,769 community-dwelling persons diagnosed with Alzheimer’s disease who initiated antiepileptic drug use in Finland were included and compared with matched non-users of these drugs.

###

For further information, please contact:

Heidi Taipale, Senior Researcher, School of Pharmacy, University of Eastern Finland, heidi.taipale(at)uef.fi

Research article:
Taipale H, Lampela P, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM. Antiepileptic drug use is associated with an increased risk of pneumonia among community-dwelling persons with Alzheimer’s disease -matched cohort study. Journal of Alzheimer’s Disease 2019, published online February 11, 2019. DOI: 10.3233/JAD-180912.

Media Contact
Heidi Taipale
[email protected]
http://dx.doi.org/10.3233/JAD-180912

Tags: AlzheimerMedicine/Healthneurobiology
Share13Tweet7Share2ShareShareShare1

Related Posts

blank

Advancing Alkene Chemistry: Homologative Difunctionalization Breakthrough

January 8, 2026
Biocompatible Ligand Enables Safe In-Cell Protein Arylation

Biocompatible Ligand Enables Safe In-Cell Protein Arylation

January 8, 2026

Monovalent Pseudo-Natural Products Boost IDO1 Degradation

January 7, 2026

Catalytic Enantioselective [1,2]-Wittig Rearrangement Breakthrough

January 7, 2026
Please login to join discussion

POPULAR NEWS

  • Enhancing Spiritual Care Education in Nursing Programs

    154 shares
    Share 62 Tweet 39
  • PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

    146 shares
    Share 58 Tweet 37
  • Robotic Ureteral Reconstruction: A Novel Approach

    63 shares
    Share 25 Tweet 16
  • Impact of Vegan Diet and Resistance Exercise on Muscle Volume

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tailored MobileNetV3Large Framework for Detecting Plant Diseases

How Organizational Support Influences Nurses’ Leadership in Tunisia

Linking Lifestyle Choices to Teen Mental Health Worldwide

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.